Background and Purpose: Increasing ischemic duration delays recovery of intracellular pH and depresses recovery of somatosensory evoked potentials. We tested whether manipulation of the rate of pH recovery influences evoked potential recovery after complete ischemia.
I ntracellular acidosis is one of several factors thought to contribute to cerebral ischemic injury. Evidence supporting a role of acidosis is largely derived from studies demonstrating a relation between lactate accumulation during ischemia and neuronal injury, particularly in those studies in which lactate accumulation is enhanced by hyperglycemia.'-3 Although the importance of acidosis during cerebral ischemia has been well documented, the importance of acidosis during reperfusion has received little attention.
During reperfusion after complete ischemia, intracellular pH (pHi) does not immediately recover to normal levels; rather, pHi recovery often lags behind recovery See Editorial Comment, page 704 of adenosine triphosphate (ATP) and restoration of the transcellular gradient of other cations. 45 Persistence of acidosis during reoxygenation may promote additional injury. For example, acidosis may interact at various points in the calcium-mediated cascade of injury processes and may promote lipid peroxidation. 6 Using phosphorus-31 magnetic resonance spectroscopy (MRS), we previously observed that increasing the duration of complete ischemia resulted in a slower rate of recovery of pH during reperfusion, and that this slower recovery rate correlated with somatosensory evoked potential (SEP) deficit. 4 However, metabolic alterations independent of pHi are also likely to contribute to SEP deficit when ischemic duration is varied.
In the present experiment, we manipulated the rate of recovery of pHi during reperfusion after a fixed duration of complete ischemia. We administered acetazolamide tion of intracellular bicarbonate ion Materials and Methods Thirty-two dogs weighing [8] [9] [10] [11] [12] kg were anesthetized with intravenous fentanyl (50 ,ug/kg) and pentobarbital (10 mg/kg), and additional pentobarbital was infused continuously at a rate of 3 mg/kg per hour throughout the experiment. Dogs were mechanically ventilated with 25-30% 02 and were catheterized for cerebral blood flow (CBF) measurements with radiolabeled microspheres as previously described.4 Temporalis muscles were fully retracted from the skull, and a catheter was inserted into the superior sagittal sinus. A straight ventricular drain catheter was inserted into the left lateral ventricle. An electrode was secured in a burr hole in the skull over the right somatosensory cortex for measuring the amplitude of the primary cortical wave complex of the SEP with left foreleg stimulation as previously described. 4 Pancuronium bromide (0.3 mg/ kg) was used as a muscle relaxant.
For MRS measurements, an inductively coupled, two-turn copper surface coil (3.5-cm diameter) was placed over the skull. With the dog lying prone in a copper cradle and the head secured in a head holder frame, the brain was positioned in the center of the homogenous magnetic field of a 1.89-T superconducting magnet with a 25.4-cm bore (Oxford Instruments, Oxford, UK). The body of the dog was wrapped in plastic and kept on a jacket perfused with warm water to maintain rectal temperature at 37°-39°C. The surface coil was doubly tuned to 32.5 MHz for obtaining phosphorus spectra and to 80.2 MHz for shimming the magnetic field on the water proton spectra. Phosphorus spectra were generated by acquiring the free induction decay over an 80-msec period after applying 100 All values are presented as mean + SEM, and p <0.05 was considered significant in all tests. Significant differences from the normocapnic reperfusion control group at a single time of reperfusion were determined by Dunnett's test when analysis of variance indicated a significant treatment effect. Significant changes from baseline values within a group were determined by the Dunnett's test when repeated-measures analysis of variance indicated a significant time effect. To determine the rate of recovery of MRS-derived variables, a mean recovery time was calculated from the recovery profile during reperfusion for each dog. We used the stochastic approach of area/height of the recovery profile. Mean recovery time equals the time integral of the difference between the preischemic value and the recovery-time profile up to a maximum of 120 minutes of reperfusion; this area is divided by the height of the difference between the preischemic and end-ischemic values.4 Mean recovery times between groups were compared by the nonparametric Mann-Whitney test.
Results
There was no significant difference among groups in baseline arterial blood gases, pH, 02 content, or glucose levels (Table 1) . Throughout reperfusion, Paco2 was maintained at approximately 40 mm Hg in the normocapnic and acetazolamide groups, at 20 mm Hg in the hypocapnic group, and at 80 mm Hg in the hypercapnic (Table 2) .
In all dogs, SEP went flat during ischemia. Recovery of SEP amplitude at 4 hours of reperfusion with hypocapnia (52+6%) was similar to that with normocapnia (52±+5%) (Figure 1 ). However, recovery was significantly depressed with both acetazolamide (23±5%) and hypercapnia (27+5%).
During complete ischemia, pHi fell from approximately 7.1 to 6.1 in all groups (Figure 2 (Table 2 ). However, there was no difference in CMRO2 among groups at any time point. There was also no difference among groups in ATP recovery, which reached a steady-state value of approximately 87% of baseline by 17.5 minutes of reperfusion. Phosphocreatine was significantly less in the acetazolamide and hypercapnic groups than in the normocapnic group at 17.5 minutes, but there were no differences thereafter Thus, acidosis may not be sufficiently severe during complete ischemia to recruit a postulated low bicarbonate-dependent mechanism. 27 Depressed SEP recovery in the acetazolamide and hypercapnic groups was not attributable to depressed CBF because delayed hypoperfusion was significant only in the normocapnic and hypocapnic groups. The lack of substantial increases in CBF in the acetazolamide and hypercapnic groups is consistent with the depressed CO2 reactivity known to occur after complete ischemia.28,29 During the immediate postischemic hyperemia, CBF in the hypercapnic and acetazolamide groups was higher than that in the hypocapnic group, although none of the groups differed from the normocapnic group (Table 2) . Thus, some degree of cerebrovascular CO2 reactivity is present during the hyperemia phase, at which time differences in pHi were also detected among groups. Temporal correspondence between the delay in normalizing postischemic pH, and the duration of postischemic hyperemia in the present study is consistent with previous observations after complete ischemia of various durations,4 further supporting a contribution of acidosis to postischemic hyperemia.
Halsey et a130 demonstrated a positive correlation between tissue Po2 during the hyperemic phase and eventual tissue damage. Whether this relation is indicative of oxygen radical damage or merely reflects reduced CMRO2 in tissue destined for necrosis is unclear. In our study, it is possible that the greater hyperemia that persisted for a longer duration in the hypercapnic and acetazolamide groups resulted in a more prolonged period of overoxygenation. Thus, we cannot exclude that excess oxygen combined with persistent acidosis augmented oxygen radical damage in these groups.
Although the present study was not designed to evaluate if persistent acidosis during reperfusion causes additional histological injury, our results demonstrate that prolonged intracellular acidosis can have a considerable impact on electrophysiological recovery. Moreover, in the normocapnic control group the duration of severe acidosis during the reperfusion period was comparable to the duration of severe acidosis during the period of complete ischemia. Thus, the duration of severe acidosis is ordinarily twice the ischemic duration.
These data suggest that therapies that accelerate pHi recovery might ameliorate ischemic/reperfusion injury.
